SCHEMBL4670965

SCHEMBL4670965

O=C(C=C(O)c1nc[nH]n1)c1cn(Cc2ccccc2F)cc1CCc1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 1/20 0.35
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
NR3C2 P08235 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
ALDH1A1 P00352 4/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
BRS3 P32247 1/20 0.33
GPR52 Q9Y2T5 1/20 0.32
HSP90AA1 P07900 1/20 0.32
MAPT P10636 3/20 0.32
TP53 P04637 2/20 0.31
RXFP1 Q9HBX9 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4675038 0.90 S1PR1 (0.32) KDM5AKDM4CKDM5BNR3C2ALDH1A1
SCHEMBL4677400 0.90 KDM4A (0.37) KDM4AKDM5AKDM4CKDM5BALDH1A1
SCHEMBL4678111 0.89 CNR1 (0.34) KDM4AKDM5AKDM4CKDM5BALDH1A1
SCHEMBL4676215 0.87 KDM4C (0.38) KDM4CNR3C2ALDH1A1KDM4EMEN1
SCHEMBL4675822 0.86 ABCB1 (0.35) KDM5AKDM4CKDM5BNR3C2ALDH1A1
SCHEMBL4676066 0.85 ALDH1A1 (0.36) ALDH1A1MEN1KMT2AL3MBTL1BRS3
SCHEMBL4673650 0.85 MAOA (0.33) ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4673837 0.85 CES1 (0.39) KDM4AKDM5AKDM4CKDM5BNR3C2
SCHEMBL4676558 0.85 ABCB1 (0.36) KDM4CTAAR1ALDH1A1KDM4EL3MBTL1
SCHEMBL4671926 0.84 LMNA (0.34) ALDH1A1KMT2AL3MBTL1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142872-B1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO (JP) 2008-10-15 EP disclosed
US-7098201-B2 Heteroaromatic derivatives having an inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2006-08-29 US disclosed
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase FUJISHITA TOSHIO (JP) 2004-01-01 US disclosed
US-6645956-B1 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment SHIONOGI & CO., LTD. (JP) 2003-11-11 US disclosed
US-6620841-B1 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) SHIONOGI & CO., LTD. (JP) 2003-09-16 US disclosed
CN-1335834-A Aromatic heterocyclic compounds having HIV integrase inhibitory activity SHIONOGI & CO (JP) 2002-02-13 CN disclosed
EP-1142872-A1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO., LTD. (JP) 2001-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase RCOR1, BCOR, CYP8B1 KDM4A 340/4885KDM5A 1534/4885KDM4C 785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.